Butyl benzyl phthalate


Literature identifierStudy typeTest dosageEffective dosageEndocrine-mediated endpointsSystems-level perturbations
PMID:11099647IVR750 mg/kg/day 750 mg/kg/dayAffects anogenital distanceReproductive endocrine-mediated perturbations
IVR750 mg/kg/day 750 mg/kg/dayUndescended testes (or cryptorchidism)Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations
IVR750 mg/kg/day 750 mg/kg/dayAffects developmental processDevelopmental endocrine-mediated perturbations
IVR750 mg/kg/day 750 mg/kg/dayDecreased testis weightsReproductive endocrine-mediated perturbations
IVR750 mg/kg/day 750 mg/kg/dayNipple retentionReproductive endocrine-mediated perturbations
IVR750 mg/kg/day 750 mg/kg/dayAffects embryonic developmentDevelopmental endocrine-mediated perturbations
PMID:11298497IVTH0.00000000000001 - 0.00001 M 0.000001 MAffects expression of progesterone receptor (PR)Reproductive endocrine-mediated perturbations
IVTH0.00000000000001 - 0.00001 M 0.000001 - 0.00001 MCancer phenotypeEndocrine-mediated cancer
PMID:11474214IVR10 mg 10 mgAffects sexual behaviorNeurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations
PMID:15883486IVTH0.000000001 - 0.001 M 0.000001 - 0.0001 MCancer phenotypeEndocrine-mediated cancer
PMID:16326419IVTH0.00001 M 0.00001 MAffects expression of estrogen receptor-alpha (ER-alpha)Reproductive endocrine-mediated perturbations
PMID:16641542IVR200 mg/kg/day 200 mg/kg/dayDecreased uterine weightsReproductive endocrine-mediated perturbations
IVR200 mg/kg/day 200 mg/kg/dayReduced sperm countsReproductive endocrine-mediated perturbations
IVR200 mg/kg/day 200 mg/kg/dayDecreased weights of epididymis in offspringDevelopmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations
IVR200 mg/kg/day 200 mg/kg/dayAffects anogenital distance in offspringDevelopmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations
IVR200 mg/kg/day 200 mg/kg/dayIncreased liver weights in offspringDevelopmental endocrine-mediated perturbations;Hepatic endocrine-mediated perturbations
IVR100 mg/kg/day 100 mg/kg/dayReduced sperm countsReproductive endocrine-mediated perturbations
IVR100 mg/kg/day 100 mg/kg/dayAffects anogenital distance in offspringDevelopmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations
IVR400 mg/kg/day 400 mg/kg/dayDecreased weights of epididymisReproductive endocrine-mediated perturbations
IVR400 mg/kg/day 400 mg/kg/dayAlterations in preputial separationReproductive endocrine-mediated perturbations
IVR400 mg/kg/day 400 mg/kg/dayReduced sperm countsReproductive endocrine-mediated perturbations
IVR400 mg/kg/day 400 mg/kg/dayChanges in epididymal morphologyReproductive endocrine-mediated perturbations
IVR400 mg/kg/day 400 mg/kg/dayDecreased spleen weights in offspringDevelopmental endocrine-mediated perturbations;Immunological endocrine-mediated perturbations
IVR400 mg/kg/day 400 mg/kg/dayAffects anogenital distance in offspringDevelopmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations
IVR400 mg/kg/day 400 mg/kg/dayAlterations in number of leydig cellsReproductive endocrine-mediated perturbations
IVR400 mg/kg/day 400 mg/kg/dayAtrophy in seminiferous tubulesReproductive endocrine-mediated perturbations
IVR400 mg/kg/day 400 mg/kg/dayIncreased liver weightsHepatic endocrine-mediated perturbations
IVR400 mg/kg/day 400 mg/kg/dayAffects testis developmentDevelopmental e
IVR400 mg/kg/day 400 mg/kg/dayIncreased weights of thyroid gland in offspring
IVR400 mg/kg/day 400 mg/kg/dayDecreased weights of seminal vesicles in offspring
PMID:18062813IVR500 mg/kg 500 mg/kgAffects mammary gland differentiationDevelopmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations
IVR500 mg/kg 500 mg/kgAlters mammary gland developmentDevelopmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations
IVR500 mg/kg 500 mg/kgIncreased uterine weightsReproductive endocrine-mediated perturbations
IVR500 mg/kg 500 mg/kgOccurrence of mammary gland tumorEndocrine-mediated cancer;Reproductive endocrine-mediated perturbations
IVR500 mg/kg 500 mg/kgAffects intracellular signaling pathwayMetabolic endocrine-mediated perturbations
PMID:21241498IVR120 mg/kg/day 120 mg/kg/dayCancer phenotypeEndocrine-mediated cancer
IVR120 mg/kg/day 120 mg/kg/dayAlterations in immune responsesImmunological endocrine-mediated perturbations
IVR120 mg/kg/day 120 mg/kg/dayAffects differentiation processDevelopmental endocrine-mediated perturbations
IVR500 mg/kg/day 500 mg/kg/dayOccurrence of mammary gland tumorEndocrine-mediated cancer;Reproductive endocrine-mediated perturbations
IVR500 mg/kg/day 500 mg/kg/dayAlterations in vaginal openingReproductive endocrine-mediated perturbations
IVR500 mg/kg/day 500 mg/kg/dayAffects differentiation processDevelopmental endocrine-mediated perturbations
IVR500 mg/kg/day 500 mg/kg/dayCancer phenotypeEndocrine-mediated cancer
IVR500 mg/kg/day 500 mg/kg/dayAlterations in immune responsesImmunological endocrine-mediated perturbations
PMID:21771643IVTH0.0000000000001 - 0.000000001 M 0.00001 MAffects xenobiotic metabolismMetabolic endocrine-mediated perturbations
PMID:25016925IVTH0.000000001 - 0.000001 M 0.000000001 - 0.000001 MCancer phenotypeEndocrine-mediated cancer
IVTH0.000000001 - 0.000001 M 0.000000001 - 0.000001 MAffects steroidogenesisReproductive endocrine-mediated perturbations
PMID:26376073IVR10 mg/L 10 mg/LAffects neural developmentDevelopmental endocrine-mediated perturbations;Neurological endocrine-mediated perturbations
IVR10 mg/L 10 mg/LAffects anogenital distanceReproductive endocrine-mediated perturbations
IVR10 mg/L 10 mg/LAffects neuronal signalingNeurological endocrine-mediated perturbations
PMID:26520405IVTH0.000000001 - 0.00005 M 0.000000001 - 0.00005 MAffects spermatogenesisReproductive endocrine-mediated perturbations
IVTH0.000000001 - 0.00005 M 0.000000001 - 0.00005 MOxidative stress in liverHepatic endocrine-mediated perturbations
PMID:26747412IVR500 mg/kg 500 mg/kgAlters sperm functionReproductive endocrine-mediated perturbations
IVR500 mg/kg 500 mg/kgInduce apoptosis of spermatogenic cellsReproductive endocrine-mediated perturbations
PMID:26895396IVR500 mg/kg/day 500 mg/kg/dayDecreased estradiol levelsReproductive endocrine-mediated perturbations
IVR500 mg/kg/day 500 mg/kg/dayAffects anogenital distanceReproductive endocrine-mediated perturbations
IVR500 mg/kg/day 500 mg/kg/dayIncreased testosterone levelsReproductive endocrine-mediated perturbations
IVR500 mg/kg/day 500 mg/kg/dayAlterations in vaginal openingReproductive endocrine-mediated perturbations
PMID:27513369IVTH0.000001 - 0.0001 M 0.00001 - 0.0001 MAffects steroidogenesisReproductive endocrine-mediated perturbations
IVTH0.000001 - 0.0001 M 0.00001 - 0.0001 MDecreased testosterone levelsReproductive endocrine-mediated perturbations
IVTH0.000001 - 0.0001 M 0.00001 - 0.0001 MIncrease in estradiol/testosterone ratioReproductive endocrine-mediated perturbations
PMID:28298639IVTH0.000001 M 0.000001 MAffects myogenic differentiationDevelopmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations
PMID:29250801IVR500 mg/kg/day 500 mg/kg/dayHyperplasia in liverHepatic endocrine-mediated perturbations
IVR500 mg/kg/day 500 mg/kg/dayAffects estrogen metabolismMetabolic endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations
IVR500 mg/kg/day 500 mg/kg/dayIncreased liver weightsHepatic endocrine-mediated perturbations
PMID:29969652IVR250 mg/kg/day 250 mg/kg/dayAffects ovarian follicles populationReproductive endocrine-mediated perturbations
IVR250 mg/kg/day 250 mg/kg/dayIncreased FSH levelsReproductive endocrine-mediated perturbations
IVR250 mg/kg/day 250 mg/kg/dayAffects ovarian functionReproductive endocrine-mediated perturbations
PMID:30243731IVTH0.01 mmol/L -No significant effects observed-
IVTH0.00001 mmol/L -No significant effects observed-
IVTH0.1 mmol/L -No significant effects observed-
IVTH0.001 mmol/L 0.001 mmol/LCancer phenotypeEndocrine-mediated cancer
IVTH0.0001 mmol/L 0.0001 mmol/LCancer phenotypeEndocrine-mediated cancer
PMID:30851587IVTH0.00001 M 0.00001 MAffects expression of estrogen receptor-alpha (ER-alpha)Reproductive endocrine-mediated perturbations

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.